ProQR Announces Results for the Second Quarter of 2017
August 16, 2017 07:00 ET
|
ProQR Therapeutics N.V.
Key updates Data from two clinical trials of QR-010 presented at the European Cystic Fibrosis Conference. Enrollment completed in the Phase 1b clinical trial in cystic fibrosis (CF) and top-line...
ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer
March 27, 2017 07:00 ET
|
ProQR Therapeutics
LEIDEN, the Netherlands, March 27, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that it appointed David M. Rodman, MD as Chief Development Strategy Officer. Dr....
ProQR to Present at Two Upcoming Investor Conferences in March
March 01, 2017 07:00 ET
|
ProQR Therapeutics
LEIDEN, the Netherlands, March 01, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for...
ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update
February 28, 2017 07:00 ET
|
ProQR Therapeutics
Key updates Major progress in the QR-010 development program for CF with presentation of positive clinical data at North American CF conference in October 2016On track to report data from the ongoing...
On a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease Day
February 27, 2017 07:00 ET
|
ProQR Therapeutics
LEIDEN, the Netherlands, Feb. 27, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
ProQR Announces Results for the Third Quarter of 2016
November 14, 2016 07:00 ET
|
ProQR Therapeutics
LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
ProQR Announces Results for the Second Quarter of 2016
August 17, 2016 07:00 ET
|
ProQR Therapeutics
LEIDEN, the Netherlands, Aug. 17, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...